Special clinical interest in cancer.
Dr Mathilda Wilding has been working in the field of cancer genetics since 2015. Mathilda is qualified as a specialist in medical oncology (cancer treatment) and clinical genetics. Mathilda is one of only a few doctors in Australia to have achieved both of these qualifications and has been appointed as a cancer genetics specialist at Royal North Shore Hospital, Sydney.
Mathilda is a Fellow of the Royal College of Physicians (FRACP) and a member of the Human Genetics Society of Australia (HGSA). She is a member of the adult and paediatric cancer genetics reference committees for the National Cancer Institute (eviQ) guidelines. She is involved in developing evidence-based genetic testing and risk management guidelines, that are used Nationally and Internationally, to guide genetic testing and the management of individuals with an inherited cause of cancer.
A dedicated teacher, she supervises and mentors training doctors and genetic counsellors from hospitals across NSW.
Mathilda’s main goal is to be a caring, respectful clinician, to listen to your concerns and provide clear and understandable explanations.
For Frequently Asked Questions and general information on cancer genetics please visit: www.preventcancer.com.au
- Human Genetics Society of Australia (HGSA)
- Cancer Genetics Reference Committees for the National Cancer Institute (eviQ)
- Fellow of Royal Australian College of Physicians (FRACP)
- Crook, A., Kwa, R., Ephraums, S., Wilding, M., Thiyagarajan, L., Fleming, J., ... & Berman, Y. (2021). The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1. Familial cancer, 1-13.
- Benn, D. E., Zhu, Y., Andrews, K. A., Wilding, M., Duncan, E. L., Dwight, T., ... & Clifton-Bligh, R. J. (2018). Bayesian approach to determining penetrance of pathogenic SDH variants. Journal of medical genetics, 55(11), 729-734.